Community access to rectal artesunate for malaria (CARAMAL): a large-scale observational implementation study in the Democratic Republic of the Congo, Nigeria and Uganda

Datasets underlying the publication "Community access to rectal artesunate for malaria (CARAMAL): a large-scale observational implementation study in the Democratic Republic of the Congo, Nigeria and Uganda": <strong>Figure 6: </strong>Number of children enrolled in the Patient Surveillance System (grey bars), and percentage of these children being administered rectal artesunate (RAS), by country. <strong>Figure 8:</strong> Overall case fatality ratio (CFR) in patients with danger signs and a positive malaria test at enrolment across the entire study period, by enrolment location and country. Data for Uganda excludes enrolments at PHCs (N=34).本数据集依托于学术论文《社区获取直肠青蒿琥酯治疗疟疾（CARAMAL）：在刚果民主共和国、尼日利亚及乌干达开展的大规模观察性实施研究》：<strong>图6：</strong>按国家分组的患者监测系统入组儿童人数（灰色柱形），以及该类儿童中接受直肠青蒿琥酯（rectal artesunate, RAS）给药的占比。<strong>图8：</strong>整个研究周期内，入组时存在危险体征且疟疾检测结果呈阳性的患者，按入组地点与国家划分的总体病例病死率（case fatality ratio, CFR）。乌干达的相关数据排除了基层医疗卫生机构（Primary Health Care, PHCs）的入组病例（样本量N=34）。